Clinical Trials & Precision Medicine 

Clinical trials are changing rapidly. As one of the most expensive parts of the drug development process we will look into how data driven technologies can bring down cost, reduce dropouts and represent real world data. 

 

CLINICAL TRIALS & PRECISION MEDICINE, Wednesday 4 December 2019

08:00

Registration and Refreshments

09:00

Keynote [Reserved for Roche CEO]

09:20

Title Sponsor

Frank Lee
09:40

Getting your data and applications ready for precision medicine

  • Learn about key capabilities of the underlying reference architecture for high performance data and AI (HPDA) to manage the ocean of data and optimize your AI and big data pipelines for analysis.
  • Understand how to improve data quality through advanced metadata management using content-based and policy-driven data classification & tagging.
  • Discover how to support hybrid multicloud workload orchestration with end-to-end automation of workflows, leveraging containers and cloud using a self-service 'App Hub'.
  • Hear about use cases from the world's fastest genomics pipeline to the largest variant database and explore how your organization can improve speed, scalability, collaboration and ease of use and gain significant cost efficiencies
Georges Heiter
10:00

New Frontiers in Data Science – the role of automation in accelerating scientific discovery

10:40

Speed Networking

11:00

Morning refreshments

round tables
11:40

Roundtables

(click to see full list)
Accelerating operations and analytics with High Speed Data sharing across platforms and the world
Laurent Martin

Laurent Martin, Aspera Pre-Sales Engineer - EMEA, IBM Global Markets

Data collection & algorithmic training for biomedical tasks: utilisation and strategies
Anastasia Georgievskaya

Anastasia Georgievskaya, General Manager, Haut.AI

Data Lakes, Getting data ready for analytics, and Personalized Health Data
Christian Blumenroehr

Christian Blumenroehr, Principal Scientist, F. Hoffmann-La Roche

Data Privacy and Democratisation
Matthew Rooney

Matthew Rooney, Chief Clinical Information Officer, Heart of England NHS Foundation Trust

Dell EMC
Design thinking: Driving forwards innovation in pharmaceuticals
Hermann Tribukait

Hermann Tribukait, Founder & CEO, ChemOS Inc.

Diagnosis based on genetic information and public ontologies and databases, improving the diagnosis process of rare disease patients with Foundation29
Pablo Botas

Pablo Botas, Head of Science, Foundation 29

Digital transformation across pharma
Jessica Federer

Jessica Federer, Ex Chief Digital Officer, Bayer

How big data is effecting precision oncology
Andrej Benjak

Andrej Benjak, Bioinformatician, University of Bern

IMI - EDHEN + BD4BO- The pro’s and con’s of the different IMI projects approaches. IT and high tech aspects. Gaining insights into the technical approaches to working with Real World Data at scale. Central vs. Federated; Working to promote FAIR principles
Matthew Wiener

Matthew Wiener, Director, Informatics And Predictive Sciences, Celgene

Investment in AI and Healthcare in China
Vibhor Gupta

Vibhor Gupta, Director and Founder, Pangaea Data

Is bad User Experience (UX) hindering drug discovery? What are the challenges and opportunities for UX in life science software and digital transformation?
Ronald Johnston

Ronald Johnston, Director Of Product And E-Commerce, Merck Digital

Lessons learned in running an AI-enabled operation for precision medicine – privacy, policy, and technical challenges and how we overcame them
Florina Ciorba

Florina Ciorba, Professor Hpc, University Basel

NTT Data
Partnerships across Pharma and Tech – Deals, IP and Timelines
Miron Tokarski

Miron Tokarski, CEO, Genomtec

Phage Display AI and Genomics – Using next generation AI and phage display to generate new immunological targets
Christian Bender

Christian Bender, Data Scientist, Bayer

Reproducibility in Bioinformatics and Big Data Analytics: Myth or Reality?
Raffaele Calogero

Raffaele Calogero, Professor, University of Torino

Roche
Roche - All4IBD: a Digital Medicine Toolkit to transform care in Inflammatory Bowel Disease (IBD)
Sumanjit Sethi

Sumanjit Sethi, Digital Health Leader, Immunology, Infectious Diseases and Ophthalmology, F. Hoffmann-La Roche Ltd

Roche - Analytical challenges with multimodal patient data: deriving drug development insights from clinico-molecular data
Gunther Jansen

Gunther Jansen, Group Director, PHC Data Science Analytics, Roche

Takeda
There is no AI without IA: Building a solid Information Architecture for your AI and high performance Precision Medicine
Frank Lee

Frank Lee, PhD, Global Healthcare and Life Sciences Industry Leader, IBM Systems

Title TBC
Visualisation of good quality data and the pursuit of metrics to drive efficiencies in clinical trials
Paolo Piraino

Paolo Piraino, Head Of Genomics And Biomarker Statistics, Bayer

Western Digital
12:30

Networking Lunch

Maria Chiara Atzori
CLINICAL TRIALS & PRECISION MEDICINE
13:35

Data Privacy and Democratization an overview

CLINICAL TRIALS & PRECISION MEDICINE
13:55

TriNetX

14:35

Afternoon Refreshments

Eleni Lagkadinou
CLINICAL TRIALS & PRECISION MEDICINE
15:10

Applications of RWE in clinical development

CLINICAL TRIALS & PRECISION MEDICINE
15:30

CENTOGENE

Michael Rebhan
CLINICAL TRIALS & PRECISION MEDICINE
15:50

Towards more integrative approaches that may allow us to intervene earlier in-patient journeys

16:10

Afternoon Refreshments

Joachim Luithle
CLINICAL TRIALS & PRECISION MEDICINE
16:50

Chairs remarks

CLINICAL TRIALS & PRECISION MEDICINE
16:55

GENALICE

David Smith
CLINICAL TRIALS & PRECISION MEDICINE
17:15

Whole Genome Sequencing and Personalized Medicine

Sonia Houston Pichardo
CLINICAL TRIALS & PRECISION MEDICINE
17:35

Patient centric digital trials and Boehringer

Armand Valsesia
CLINICAL TRIALS & PRECISION MEDICINE
17:55

Precision Nutrition and Metabolic Diseases

18:15

Drinks Reception

last published: 22/Oct/19 09:35

CLINICAL TRIALS & PRECISION MEDICINE, Thursday 5 December 2019

08:30

Presentation [Reserved Novartis CEO]

10:00

Western Digital

11:05

Networking break

round tables
11:45

Roundtables

(Click to see full list)
Analytical challenges with multimodal patient data: deriving drug development insights from clinico-molecular data
Gunter Jansen

Gunter Jansen, Group Director, PHC Data Science Analytics, Roche

Data privacy sharing and analytics how technology can help
Andrew Roddam

Andrew Roddam, Vice President And Global Head Epidemiology, GSK

DELL
Developing a Spin in Bioinformatics Company
Nadeem Sarwar

Nadeem Sarwar, Founder And President, Eisai

Digital Biomarkers as endpoints in clinical trials: an opportunity for Personalised Healthcare
Christian Gossens

Christian Gossens, Digital Biomarker Informatics; Global Area Head; pRED Informatics, Roche

Digital transformation in pharma
Jessica Federer

Jessica Federer, Ex Chief Digital Officer, Bayer

Digital Transformation of Health Care
Markus Mäkelä

Markus Mäkelä, Co-Founder, PredictCare LLC

Educating data scientists for the pharmaceutical industry
Jake Chen

Jake Chen, Chief Bioinformatics Officer, University of Alabama at Birmingham

IBM
IMI - The need for data communities in Europe, and why should you care? Looking ahead to an integrated European research meeting the need for RWD in a global environment.
Kiliana Suzart-Woischnik

Kiliana Suzart-Woischnik, Epidemiology Director, Bayer

Learnings and results from large-scale investments in data across the pharmaceutical R&D chain
Greg Temesi

Greg Temesi, Director, R&D It - Product Strategy, Merck

Point of Care Diagnostics
Miron Tokarski

Miron Tokarski, CEO, Genomtec

Roche - All4IBD: a Digital Medicine Toolkit to transform care in Inflammatory Bowel Disease (IBD)
Sumanjit Sethi

Sumanjit Sethi, Digital Health Leader, Immunology, Infectious Diseases and Ophthalmology, F. Hoffmann-La Roche Ltd

Stop talking about the principles, start showing what FAIR really means - Gaps in IT capabilities to support FAIR data and services
Martin Romacker

Martin Romacker, Data And Information Architect, Roche

Wearable data and challenges around it that involve data ingestion, technology required for computation, data preprocessing and transformation and advanced analytics methods
Stephan Cichos

Stephan Cichos, Principal Data Manager, Bayer

Western Digital
Colm Carroll
12:30

IMI Lunchtime Panel- It is now or never! Connecting data communities with clinical research communities

How do we link research interests at scale and across data permeable borders in Europe? Building at scale communities; Expanding the FAIR principles in the EU; Understanding the quid pro quo between data partners and researchers.
  • Building at scale communities
  • Expanding the FAIR principles in the EU
  • Understanding the quid pro quo between data partners and researcher
Colm Carroll, Scientific Project Manager, Innovative Medicines Initiative
12:30

Lunch

14:35

Afternoon Refreshments

16:30

Afternoon Refreshments

18:05

Close of Conference

last published: 22/Oct/19 09:35

 

Contact us

To sponsor or exhibit contact:
Alistair Wilmot
+44 (0)207 092 1174

alistair.wilmot@terrapinn.com


To speak:
Chris Shanks
+44 (0)207 092 1151

chris.shanks@terrapinn.com